Ignite Creation Date:
2024-05-05 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00422786
Status:
COMPLETED
Last Update Posted:
2008-07-15
First Post:
2007-01-12
Brief Title:
Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma
Sponsor:
Thallion Pharmaceuticals
Organization:
Thallion Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03
Start Date Type:
None
Primary Completion Date:
2008-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-12
First Submit QC Date:
January 12 2007
Study First Post Date:
2007-01-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-07-10
Last Update Post Date:
2008-07-15
Last Update Post Date Type:
ESTIMATED